NVST Logo

Envista Holdings Corporation (NVST) 

NYSE
Market Cap
$3.7B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
114 of 775
Rank in Industry
8 of 48

Largest Insider Buys in Sector

NVST Stock Price History Chart

NVST Stock Performance

About Envista Holdings Corporation

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, …

Insider Activity of Envista Holdings Corporation

Over the last 12 months, insiders at Envista Holdings Corporation have bought $906,708 and sold $0 worth of Envista Holdings Corporation stock.

On average, over the past 5 years, insiders at Envista Holdings Corporation have bought $661,893 and sold $18.04M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Keel Paul A (Chief Executive Officer) — $1.01M. Hammes Eric D. (Chief Financial Officer) — $801,215.

The last purchase of 30,000 shares for transaction amount of $506,100 was made by Keel Paul A (Chief Executive Officer) on 2024‑08‑13.

List of Insider Buy and Sell Transactions, Envista Holdings Corporation

2024-08-13PurchaseChief Executive Officer
30,000
0.0181%
$16.87$506,1000.00%
2024-08-12PurchaseChief Financial Officer
24,532
0.0144%
$16.33$400,608+15.29%
2023-11-16PurchaseSVP, Orthodontics
2,185
0.0013%
$22.89$50,015-12.27%
2023-11-08PurchaseGeneral Counsel
5,000
0.0029%
$21.75$108,750-6.66%
2023-11-06PurchaseChief Executive Officer
10,000
0.0059%
$21.53$215,253-5.26%
2023-11-06PurchasePrincipal Financial Officer
2,000
0.0012%
$21.53$43,060-5.26%
2023-02-28SaleChief Financial Officer
10,016
0.006%
$37.90$379,606-17.47%
2022-11-17SaleChief Financial Officer
657
0.0004%
$36.55$24,013-6.69%
2022-04-18SaleChief Financial Officer
5,341
0.0033%
$45.73$244,244-16.99%
2022-03-29SaleChief Executive Officer
3,801
0.0025%
$51.50$195,752-22.61%
2022-03-18SaleChief Executive Officer
6,737
0.0041%
$49.75$335,166-23.85%
2022-03-18SaleChief Financial Officer
4,786
0.003%
$50.86$243,416-23.85%
2022-03-18SaleSVP, Strategy & Bus. Dev.
10,092
0.0062%
$50.00$504,600-23.85%
2022-03-16SaleChief Executive Officer
8,982
0.0055%
$47.75$428,891-20.24%
2022-03-01SaleChief Human Resources Officer
4,181
0.0026%
$47.83$199,977-19.50%
2022-03-01SaleSVP, Strategy & Bus. Dev.
2,958
0.0018%
$47.83$141,481-19.50%
2022-02-25SaleChief Financial Officer
7,196
0.0044%
$47.81$344,041-20.93%
2022-02-25SaleChief Human Resources Officer
16,892
0.0102%
$47.71$805,917-20.93%
2022-02-25SaleSVP, Strategy & Bus. Dev.
18,574
0.0112%
$47.65$884,963-20.93%
2022-02-11SaleSVP, Strategy & Bus. Dev.
12,112
0.0076%
$47.50$575,320-17.65%

Insider Historical Profitability

<0.0001%
Keel Paul AChief Executive Officer
402605
0.2339%
$21.5010
Hammes Eric D.Chief Financial Officer
24532
0.0143%
$21.5010
Aghdaei AmirChief Executive Officer
295362
0.1716%
$21.50212<0.0001%
Conley EricSVP, Orthodontics
47376
0.0275%
$21.5010
Bludworth Curt WChief Human Resources Officer
46759
0.0272%
$21.5016<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$442.78M12.0520.71M+13.3%+$51.98M0.01
The Vanguard Group$366.44M9.9717.14M-0.17%-$609,158.960.01
Morgan Stanley$361.43M9.8416.91M+3.81%+$13.26M0.03
Harris Associates$208.66M5.689.76M-10.07%-$23.36M0.34
Ariel Investments$190.12M5.178.89M+25.3%+$38.38M1.87
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.